Kathleen Ludwig

566 total citations
15 papers, 362 citations indexed

About

Kathleen Ludwig is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kathleen Ludwig has authored 15 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kathleen Ludwig's work include Acute Lymphoblastic Leukemia research (6 papers), Neuroblastoma Research and Treatments (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Kathleen Ludwig is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Neuroblastoma Research and Treatments (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Kathleen Ludwig collaborates with scholars based in United States, Germany and Norway. Kathleen Ludwig's co-authors include Jason E. Toombs, Noah Sorrelle, James B. Lorens, Rolf A. Brekken, Tanya Watt, Theodore W. Laetsch, Holly Pacenta, Erin Butler, Laura J. Klesse and Shinichi Yabuuchi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PEDIATRICS.

In The Last Decade

Kathleen Ludwig

14 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathleen Ludwig United States 6 168 160 90 50 42 15 362
Kerstin L. Edlefsen United States 11 168 1.0× 60 0.4× 36 0.4× 29 0.6× 40 1.0× 23 365
Justyna Sakowska Poland 11 73 0.4× 154 1.0× 53 0.6× 46 0.9× 20 0.5× 20 329
Arun K. Singavi United States 6 242 1.4× 76 0.5× 26 0.3× 28 0.6× 44 1.0× 14 350
Tomoyuki Ichimura Japan 13 144 0.9× 67 0.4× 96 1.1× 59 1.2× 80 1.9× 49 549
Georgios Paterakis Greece 10 92 0.5× 101 0.6× 77 0.9× 13 0.3× 23 0.5× 32 368
Rina K Patel United States 7 134 0.8× 60 0.4× 58 0.6× 23 0.5× 114 2.7× 9 356
Michela Ballardini Italy 11 152 0.9× 52 0.3× 47 0.5× 159 3.2× 57 1.4× 16 347
Anna Colpo Italy 11 71 0.4× 59 0.4× 133 1.5× 47 0.9× 14 0.3× 24 376
Karim ElSahwi United States 12 167 1.0× 80 0.5× 134 1.5× 116 2.3× 52 1.2× 25 527
Pasquale Barbaro Australia 10 124 0.7× 126 0.8× 133 1.5× 41 0.8× 24 0.6× 25 453

Countries citing papers authored by Kathleen Ludwig

Since Specialization
Citations

This map shows the geographic impact of Kathleen Ludwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Ludwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Ludwig more than expected).

Fields of papers citing papers by Kathleen Ludwig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Ludwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Ludwig. The network helps show where Kathleen Ludwig may publish in the future.

Co-authorship network of co-authors of Kathleen Ludwig

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Ludwig. A scholar is included among the top collaborators of Kathleen Ludwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Ludwig. Kathleen Ludwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Laetsch, Theodore W., Stephan D. Voss, Kathleen Ludwig, et al.. (2024). Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric NTRK Fusion–Positive Solid Tumors (Children's Oncology Group ADVL1823). Journal of Clinical Oncology. 43(10). 1188–1197. 4 indexed citations
2.
Brown, Austin L., Olga A. Taylor, M. Brooke Bernhardt, et al.. (2024). Evaluation of Methotrexate Pharmacogenomic Variants to Predict Acute Neurotoxicity in Children with Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 4190–4190. 1 indexed citations
3.
4.
5.
Laetsch, Theodore W., Kathleen Ludwig, David Hall, et al.. (2023). Phase 2 study of larotrectinib in children with newly diagnosed infantile fibrosarcoma (IFS): Children’s Oncology Group (COG) ADVL1823 cohort A.. Journal of Clinical Oncology. 41(16_suppl). 10008–10008. 4 indexed citations
6.
Zheng, Ruifang, Franklin Fuda, Jeffrey Gagan, et al.. (2023). Genomic heterogeneity within B/T mixed phenotype acute leukemia in a context of an immunophenotype. Leukemia Research Reports. 21. 100410–100410. 5 indexed citations
7.
Smith, Caroline, Ryan Huang, Jingjing Xie, et al.. (2022). LILRB4 Is a Novel Target for KMT2A Rearranged Acute Leukemia. Blood. 140(Supplement 1). 7423–7424. 3 indexed citations
8.
9.
Butler, Erin, Kathleen Ludwig, Holly Pacenta, et al.. (2021). Recent progress in the treatment of cancer in children. CA A Cancer Journal for Clinicians. 71(4). 315–332. 63 indexed citations
10.
Laetsch, Theodore W., Kathleen Ludwig, Donald A. Barkauskas, et al.. (2020). A phase II study of larotrectinib for children with newly diagnosed solid tumors and relapsed acute leukemias harboring TRK fusions: Children’s Oncology Group study ADVL1823.. Journal of Clinical Oncology. 38(15_suppl). TPS10560–TPS10560. 2 indexed citations
11.
Mir, Adnan, Nnenna G. Agim, Alex A. Kane, et al.. (2019). Giant Congenital Melanocytic Nevus Treated With Trametinib. PEDIATRICS. 143(3). 37 indexed citations
12.
Kelm, Sørge, Meena Bedi, Jessica Thomas, et al.. (2018). The Impact of Hemoglobin on Outcomes in Anal Canal Cancer Treated with Definitive Chemoradiation. International Journal of Radiation Oncology*Biology*Physics. 102(3). e9–e9. 1 indexed citations
13.
Ludwig, Kathleen, Wenting Du, Noah Sorrelle, et al.. (2017). Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer. Cancer Research. 78(1). 246–255. 119 indexed citations
14.
Kirane, Amanda, Kathleen Ludwig, Noah Sorrelle, et al.. (2015). Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. Cancer Research. 75(18). 3699–3705. 108 indexed citations
15.
Köhler, K, G. Haroske, & Kathleen Ludwig. (2006). Therapie von Pankreasmetastasen beim Nierenzellkarzinom - Eine Fallbeschreibung von 5 Patienten. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 131(5). 425–428. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kerstin L. Edlefsen Breakdown of academic impact, for papers by Justyna Sakowska Breakdown of academic impact, for papers by Arun K. Singavi Breakdown of academic impact, for papers by Tomoyuki Ichimura Breakdown of academic impact, for papers by Georgios Paterakis Breakdown of academic impact, for papers by Rina K Patel Breakdown of academic impact, for papers by Michela Ballardini Breakdown of academic impact, for papers by Anna Colpo Breakdown of academic impact, for papers by Karim ElSahwi Breakdown of academic impact, for papers by Pasquale Barbaro
Rankless by CCL
2026